Gina Wadas
-
Sure, you know how old you are, but what about your cells? Are they the same age? Are they older, younger? Why does it matter? Led by scientists at Johns Hopkins… Read More
-
Cancer is an international issue and there is much effort in trying to understand the disease’s functions and mechanisms to combat its devastating effects. At INBT, one of the Institute’s… Read More
-
Johns Hopkins University’s Institute for NanoBioTechnology has a reputation not only for conducting cutting edge research at the interface of nanoscience, engineering, and medicine, but also for nurturing the next… Read More
-
By combining two treatment strategies, both aimed at boosting the immune system’s killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. And, they say, because the combination technique is easily tailored to different types of cancer, their findings — if confirmed in humans — have the potential to enhance treatment options for a wide variety of cancer patients. Read More
-
In a microscopic feat that resembled a high-wire circus act, Johns Hopkins researchers have coaxed DNA nanotubes to assemble themselves into bridge-like structures arched between two molecular landmarks on the… Read More
-
Blood vessels play a dual role in healing as well as spreading diseases in the body. While vascular systems carry vital nutrients, they are also a pathway for malignancies to infiltrate other body systems. The challenge for researchers is encouraging blood vessel formation in one instance, while inhibiting formation in another. Such was the theme of the 11th annual Johns Hopkins Nano-Bio Symposium, Engineering Vascularization, on Friday, May 5, 2017 at the Johns Hopkins School of Medicine. The symposium was jointly organized by Johns Hopkins Institute for NanoBioTechnology (INBT) and Physical Sciences-Oncology Center (PS-OC). Read More
